Long‐term outcomes of children with ulcerative colitis after acute severe colitis: A GETAID pédiatrique multicenter study

Journal of Pediatric Gastroenterology and Nutrition 2026 Open access

Read full text
Authors: Manon Cochet, A. Beauvais, Frank Ruemmele, Raphael Enaud, Thierry Lamireau, Rémi Duclaux‐Loras, Claire Dupont, Stéphanie Willot, Laure Bridoux‐Henno, Georges Dimitrov, Julie Lemale, Vincent Guinard‐Samuel
+7 more V Bertrand, Anne Laure Breton, Christine Martinez Vinson, Stéphanie Coopman, Delphine Ley, Bénédicte Pigneur, and the Groupe d'Etudes Thérapeutiques des Affections Inflammatoires du tube Digestif (GETAID) pédiatrique
DOI: 10.1002/jpn3.70433
Cited by: 1
References: 32

Abstract

OBJECTIVES: Acute severe colitis (ASC) is a frequent and severe complication of ulcerative colitis (UC) with a high risk of colectomy. Effects of immunosuppressants and anti-tumor necrosis factor (anti-TNF) agents on the risk of colectomy remain debated. We wished to study the evolution of French pediatric-onset UC patients after ASC. METHODS: This retrospective study was conducted in 12 French centers of the GETAID pédiatrique group. Data on patients with UC aged

Fields of Study & Subjects

Inflammatory Bowel Disease Infant Nutrition and Health Microscopic Colitis

Publication details

Journal / source
Journal of Pediatric Gastroenterology and Nutrition
Publisher
Wiley
Volume
83
Issue
1
Pages
117–126
Publication date
3 April 2026
Language
EN